Stephanie Earnshaw

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Economic impact of alvimopan considering varying definitions of postoperative ileus

Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients

Factor VIII alloantibody inhibitors: Cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected aspergillus invasive fungal infections in China

Budgetary impact on a U.S. health plan after adopting umeclidinium/vilanterol (UMEC/VI) for the management of moderate-to-severe COPD

Treatment interruptions and regimen changes in first-generation vs. second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia

Treatment interruption and regimen change in first-generation versus second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia

Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs

Academy of Managed Care Pharmacy (Amcp) Dossiers: Use in Health Care Decision Making

Health Care Cost Savings Associated with Aripiprazole Once-Monthly (Aom) Treatment Among Schizophrenia Patients with Psychiatric Hospitalizations Prior to Aom Treatment Initiation

Using the coronary artery calcium score to guide statin therapy: A cost-effectiveness analysis

Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men

Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges

Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-To-Severe Rheumatoid Arthritis

Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

Spillover adherence effects of fixed-dose combination HIV therapy

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands

Economic analysis: Randomized, placebo-controlled clinical trial of dutasteride in men at high risk for prostate cancer

Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial